PATENT CLAIM ANALYSIS

Application Number: 15988790
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "180000"]

Abstract:
The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where R 1 , R 2 , R 3 , R 4 , R 5 , R 5′ , R 6 , X 1 , X 2 , m, and n are described herein.

Claim (Index 51):
The compound of  claim 50 , wherein R 2  is heterocycloalkyl, optionally substituted with one or more R 8 .

Metadata:
- Claim Count in Document: 131.0
- Percentile: 93.0
- Lexical Diversity: 1.88372
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14982131', '15015566', '15015563', '15909200', '15837393']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8282049445858662
- 35 USC 102 Novelty (BERT): 0.61092556690978
- Combined Prediction Score: 0.8064770068182576
- Mean Citation Score: 516.881088
- Max Citation Score: 547.2387
- Similarity Product: 500.80819634213447

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test